company background image
C2C logo

Concord Medical Services Holdings DB:C2C Stock Report

Last Price

€6.25

Market Cap

€28.5m

7D

0%

1Y

-45.7%

Updated

11 Oct, 2024

Data

Company Financials

Concord Medical Services Holdings Limited

DB:C2C Stock Report

Market Cap: €28.5m

C2C Stock Overview

Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

C2C fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Concord Medical Services Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Concord Medical Services Holdings
Historical stock prices
Current Share PriceUS$6.25
52 Week HighUS$36.00
52 Week LowUS$3.26
Beta-0.25
11 Month Change0%
3 Month Change-24.24%
1 Year Change-45.65%
33 Year Change-72.59%
5 Year Change-69.95%
Change since IPO-89.50%

Recent News & Updates

Recent updates

Shareholder Returns

C2CDE HealthcareDE Market
7D0%-2.1%0.8%
1Y-45.7%22.6%14.0%

Return vs Industry: C2C underperformed the German Healthcare industry which returned 22.8% over the past year.

Return vs Market: C2C underperformed the German Market which returned 11.8% over the past year.

Price Volatility

Is C2C's price volatile compared to industry and market?
C2C volatility
C2C Average Weekly Movementn/a
Healthcare Industry Average Movement3.6%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: C2C's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine C2C's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997727Jianyu Yangwww.concordmedical.com

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Concord Medical Services Holdings Limited Fundamentals Summary

How do Concord Medical Services Holdings's earnings and revenue compare to its market cap?
C2C fundamental statistics
Market cap€28.49m
Earnings (TTM)-€49.01m
Revenue (TTM)€61.00m

0.5x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
C2C income statement (TTM)
RevenueCN¥471.70m
Cost of RevenueCN¥552.48m
Gross Profit-CN¥80.78m
Other ExpensesCN¥298.15m
Earnings-CN¥378.93m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-87.28
Gross Margin-17.13%
Net Profit Margin-80.33%
Debt/Equity Ratio175.4%

How did C2C perform over the long term?

See historical performance and comparison